A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly-Reference-Cited by-同舟云学术

A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly

Published:2008-08-01 Issue:8 Volume:93 Page:2957-2968
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Murray Robert D.¹,Melmed Shlomo²

Affiliation:

1. Department of Endocrinology (R.D.M.), Leeds Teaching Hospitals National Health Service Trust, Leeds LS9 7TF, United Kingdom

2. Department of Medicine (S.M.), Cedars Sinai Medical Center, University of California Los Angeles School of Medicine, Los Angeles, California 90048

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/93/8/2957/9052340/jcem2957.pdf

Reference65 articles.

1. Medical progress: acromegaly.;Melmed;N Engl J Med,2006

2. An audit of outcome of treatment in acromegaly.;Bates;Q J Med,1993

3. Systemic complications of acromegaly: epidemiology, pathogenesis, and management.;Colao;Endocr Rev,2004

4. Factors influencing mortality in acromegaly.;Holdaway;J Clin Endocrinol Metab,2004

5. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.;Orme;J Clin Endocrinol Metab,1998

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of biochemical response to somatostatin receptor ligands in acromegaly;Best Practice & Research Clinical Endocrinology & Metabolism;2024-07

2. Personalized Medicine in Acromegaly: The ACROFAST Study;The Journal of Clinical Endocrinology & Metabolism;2024-06-29

3. Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells;Frontiers in Pharmacology;2024-02-05

4. Efficacy and Safety of Pegvisomant in the Treatment of Acromegaly;Archives of Medical Research;2023-12

5. Predictors of Response to Treatment with First-Generation Somatostatin Receptor Ligands in Patients with Acromegaly;Archives of Medical Research;2023-12